Core Laboratories Nv Stock Today

CLB Stock  USD 16.99  0.30  1.80%   

Performance

6 of 100

 
Weak
 
Strong
Modest

Odds Of Distress

Less than 1

 
High
 
Low
Very Small
Core Laboratories is trading at 16.99 as of the 18th of April 2024, a 1.80 percent up since the beginning of the trading day. The stock's open price was 16.69. Core Laboratories has a very small chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for Core Laboratories NV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of March 2024 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain
Energy
IPO Date
20th of September 1995
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. The company has 46.66 M outstanding shares of which 6.59 M shares are currently shorted by investors with about 17.61 days to cover. More on Core Laboratories NV

Moving together with Core Stock

  0.88NR Newpark Resources Financial Report 7th of May 2024 PairCorr
  0.72TS Tenaris SA ADR Earnings Call This WeekPairCorr
  0.66EFXT Enerflex Financial Report 1st of May 2024 PairCorr

Moving against Core Stock

  0.46NOA North American Const Earnings Call This WeekPairCorr

Core Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Core Laboratories' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Core Laboratories or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ChairmanLawrence Bruno
Thematic IdeaPetroleum and Natural Gas (View all Themes)
Old Names[ATEX Resources Inc, Core Laboratories NV, Candy Club Holdings Ltd]
Business ConcentrationOil & Gas Equipment & Services, Energy, NYSE Composite, SP Small-Cap 600, Dow Jones Oil, PHLX Oil Service, Petroleum and Natural Gas, Energy, Energy Equipment & Services, Oil & Gas Equipment & Services, Energy (View all Sectors)
Average Analyst Recommendation
Analysts covering Core Laboratories report their recommendations after researching Core Laboratories' financial statements, talking to executives and customers, or listening in on Core Laboratories' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Core Laboratories. The Core consensus assessment is calculated by taking the average forecast from all of the analysts covering Core Laboratories.
Financial Strength
Based on the key indicators related to Core Laboratories' liquidity, profitability, solvency, and operating efficiency, Core Laboratories NV is performing exceptionally good at this time. It has a great probability to report excellent financial results in May. Financial strength of Core Laboratories is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.890.8694
Fairly Up
Slightly volatile
Gross Profit Margin0.20.1845
Significantly Up
Slightly volatile
Net Debt187 M200.3 M
Significantly Down
Pretty Stable
Total Current Liabilities100.6 M88.1 M
Fairly Up
Very volatile
Non Current Liabilities Total267.2 M268.5 M
Slightly Down
Pretty Stable
Total Assets550.2 M586.4 M
Notably Down
Pretty Stable
Total Current Assets225 M223.1 M
Slightly Up
Very volatile
Total Cash From Operating Activities23.5 M24.8 M
Notably Down
Slightly volatile
Core Laboratories' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Core Laboratories' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Core Laboratories' financial leverage. It provides some insight into what part of Core Laboratories' total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Core Laboratories' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Core Laboratories deploys its capital and how much of that capital is borrowed.
Liquidity
Core Laboratories cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 215.38 M in debt with debt to equity (D/E) ratio of 1.29, which is OK given its current industry classification. Core Laboratories has a current ratio of 2.19, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Core Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, Core Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Core Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Core to invest in growth at high rates of return. When we think about Core Laboratories' use of debt, we should always consider it together with cash and equity.

Change To Inventory

(12.33 Million)
Core Laboratories NV (CLB) is traded on New York Stock Exchange in USA. It is located in 6316 Windfern Road, Houston, TX, United States, 77040 and employs 3,600 people. Core Laboratories is listed under Oil & Gas Equipment & Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 811.03 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Core Laboratories's market, we take the total number of its shares issued and multiply it by Core Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Core Laboratories runs under Energy Equipment & Services sector within Energy industry. The entity has 46.66 M outstanding shares of which 6.59 M shares are currently shorted by investors with about 17.61 days to cover. Core Laboratories NV has about 15.43 M in cash with 24.79 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29.
Check Core Laboratories Probability Of Bankruptcy
Ownership Allocation
Core Laboratories retains a total of 46.66 Million outstanding shares. The majority of Core Laboratories NV outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Core Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Core Laboratories. Please pay attention to any change in the institutional holdings of Core Laboratories NV as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Core Ownership Details

Core Stock Price Odds Analysis

What are Core Laboratories' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Core Laboratories jumping above the current price in 90 days from now is about 15.41%. The Core Laboratories NV probability density function shows the probability of Core Laboratories stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.1854 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Core Laboratories will likely underperform. Additionally, core Laboratories NV has an alpha of 0.048, implying that it can generate a 0.048 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 16.99HorizonTargetOdds Above 16.99
84.47%90 days
 16.99 
15.41%
Based on a normal probability distribution, the odds of Core Laboratories to move above the current price in 90 days from now is about 15.41 (This Core Laboratories NV probability density function shows the probability of Core Stock to fall within a particular range of prices over 90 days) .

Core Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Core Laboratories that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Core Laboratories' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Core Laboratories' value.
InstituionRecorded OnShares
Royce & Associates, Lp2023-12-31
914.3 K
Fisher Asset Management, Llc2023-12-31
754.4 K
Disciplined Growth Investors Inc2023-12-31
752.4 K
Morgan Stanley - Brokerage Accounts2023-12-31
727.5 K
Van Eck Associates Corporation2023-12-31
586.4 K
Charles Schwab Investment Management Inc2023-12-31
580.4 K
Northern Trust Corp2023-12-31
494.3 K
Bank Of New York Mellon Corp2023-12-31
464 K
Amvescap Plc.2023-12-31
412.5 K
Ariel Investments, Llc2023-12-31
M
Blackrock Inc2023-12-31
M
View Core Laboratories Diagnostics

Core Laboratories Historical Income Statement

Core Laboratories NV Income Statement is one of the three primary financial statements used for reporting Core's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Core Laboratories revenue and expense. Core Laboratories Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Core Laboratories' Depreciation And Amortization is projected to decrease significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 619.3 M, whereas Interest Expense is forecasted to decline to about 10.1 M. View More Fundamentals

Core Stock Against Markets

Picking the right benchmark for Core Laboratories stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Core Laboratories stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Core Laboratories is critical whether you are bullish or bearish towards Core Laboratories NV at a given time. Please also check how Core Laboratories' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Core Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Latest Portfolios Now

   

Latest Portfolios

Quick portfolio dashboard that showcases your latest portfolios
All  Next Launch Module

Core Laboratories Corporate Directors

Core Laboratories corporate directors refer to members of a Core Laboratories board of directors. The board of directors generally takes responsibility for the Core Laboratories' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Core Laboratories' board members must vote for the resolution. The Core Laboratories board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Charles DunlapIndependent Member of the Board of Supervisory DirectorsProfile
Richard BergmarkCFO, Executive VP and Supervisory DirectorProfile
Michael KearneyIndependent Supervisory DirectorProfile
Margaret KempenIndependent Member of the Board of Supervisory DirectorsProfile

How to buy Core Stock?

Before investing in Core Laboratories, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Core Laboratories. To buy Core Laboratories stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Core Laboratories. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Core Laboratories stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Core Laboratories NV stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Core Laboratories NV stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Core Laboratories NV, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Core Stock please use our How to Invest in Core Laboratories guide.

Already Invested in Core Laboratories NV?

The danger of trading Core Laboratories NV is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Core Laboratories is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Core Laboratories. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Core Laboratories is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Complementary Tools for Core Stock analysis

When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamental Analysis
View fundamental data based on most recent published financial statements
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Global Correlations
Find global opportunities by holding instruments from different markets
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.72)
Dividend Share
0.04
Earnings Share
0.51
Revenue Per Share
10.92
Quarterly Revenue Growth
0.005
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.